As a new type of foreign trade service provider driven by technological transformation and foreign trade services, HiSiaddi has more than ten years of in-depth experience in cosmetic ingredients and daily chemical products. It has long-term observation and in-depth research on the glabridin trading market. This article focuses on glabridin, conducting in-depth discussion from four dimensions: new global market trends, opportunities and challenges for downstream B-end buyers, targeted competitiveness improvement strategies, and core difference summary. It aims to provide valuable references for your global procurement and market layout.
Glabridin is no longer an exclusive ingredient for a few countries or brands. It has entered a new stage featuring global supply chain restructuring, bifurcated technical routes, stricter compliance regulations, and cross-industry application expansion.
The global market size maintains steady growth: it reached approximately USD 40 million in 2025 and is projected to hit USD 63 million by 2032, with a compound annual growth rate of about 6.8%. Price stratification is more prominent:
High-purity grade (≥98%): Exclusively for whitening special-certified products and high-end medical beauty lines. Prices remain firm and supplies are tight due to an extremely low natural extraction yield (around 0.03%), coupled with increasingly stringent global standards for heavy metals, solvent residues and microorganisms.
Medium and low purity grade (20%–90%): Applied in general skin repair, anti-inflammation, sun protection and daily chemical compound formulations. Supply is relatively sufficient with severe price fluctuations and red ocean competition.
In short, high-end buyers are scrambling for stock, while mid-to-low-end players are engaged in price wars. Global buyers are reselecting their positioning segments.
In the past, high-purity glabridin was mainly produced by traditional extraction processes from Japanese, South Korean and a few European and American enterprises. Currently, two routes operate in parallel, rewriting the global supply landscape:
Traditional Extraction (Mainstream): Production capacity is rising in major licorice producing countries including China, Turkey, Iran and Greece. Nevertheless, high-purity production capacity remains scarce, and supply is highly unstable due to impacts from environmental protection policies, pesticide residues, climate and planting regulations.
Biosynthesis (Future Growth Driver): Synthetic biology routes such as yeast fermentation and enzymatic catalysis are accelerating pilot-scale testing and industrialization. The long-term goal is cost reduction, capacity expansion and reduced reliance on wild licorice resources.
For global buyers, 2026–2028 will be a transition period: natural high-purity glabridin will remain rigid demand, while biosynthesis products will gradually increase in volume. In the short term, high-purity, stable and compliance-recordable raw materials will still be in short supply.
Purchasing glabridin now involves more than just purity and price. Global regulatory and brand requirements are rapidly converging:
Tougher Regulations: Europe, America, China and South Korea all mandate raw material filing, COA certificates, full documentation covering heavy metals/pesticide residues/microorganisms/solvent residues and microbial limit standards. Whitening special-certified products impose stricter impurity control requirements.
ESG & Traceability: Major brands (L'Oréal, Estée Lauder, AmorePacific, etc.) require sustainable planting, GAP bases, carbon footprint accounting, ethical procurement and blockchain traceability.
Converged Certifications: Globally recognized certifications such as COSMOS, ECOCERT, HALAL and GMP have become mainstream prerequisites. Without relevant certifications, entry into mainstream channels is impossible.
In one sentence: Compliance, traceability and sustainability have become the unified global "market access ticket".
Glabridin was once simply defined as a "whitening ingredient"; its application boundaries have now expanded significantly:
Core Skincare: Whitening and spot fading, anti-inflammatory repair, anti-allergy soothing, antioxidant and anti-photoaging, especially suitable for sensitive skin and post-procedure repair.
Sun Protection & Outdoor Products: Antioxidation and anti-photodamage effects enhance the stability of sunscreen systems, driving rapid consumption growth in outdoor scenarios. Oral
Functional Foods: Fast-growing applications in whitening gummies, anti-allergy capsules and anti-inflammatory dietary supplements across Japan, South Korea, Southeast Asia and China.
Medical Aesthetics & Professional Lines: Rising demand for clinical efficacy verification in post-procedure repair, anti-inflammatory redness reduction and pigment management.
This means downstream buyers are no longer limited to cosmetic manufacturers; food, medical aesthetics and pharmaceutical enterprises are entering the market, leading to a more complex demand structure and differentiated procurement standards.
Global B-end buyers are categorized into four groups: large international beauty groups, mid-to-high-end local brands, emerging small & medium brands/factories, and cross-industry new players (food/medical aesthetics). Each group faces distinct pain points and opportunities, requiring differentiated operation strategies.
Characteristics: Large procurement volume, sufficient budget, extremely strict standards, global multi-warehouse layout, long-term agreement-based procurement and strong bargaining power.
Core Challenges
Insufficient stable supply of high-purity products: Global high-purity production capacity is limited, resulting in peak-season stock shortages, long delivery cycles and high risk of supply disruption.
High compliance and ESG costs: Global certifications, traceability systems and carbon footprint verification require long supplier screening and audit cycles with high investment costs.
Difficulty balancing price and quality: High-purity and low-impurity requirements conflict with stable long-term pricing; limited qualified suppliers weaken negotiation leverage.
Core Opportunities
Supply chain integration advantages: Leverage scale and standards to lock high-quality production capacity, deeply bind technology-oriented suppliers, and even co-develop customized specifications.
High ingredient premium space: Strong market recognition of glabridin as the "Whitening Gold" supports high-end product pricing and high gross profit margins.
Global standard dominance: Participate in formulating industry standards for purity, impurities, detection methods and sustainability to build industrial barriers.
Characteristics: Moderate procurement volume, cost-performance orientation, positioning in natural/plant-derived/repair skincare, regional market focus, compliance sensitivity with limited budgets.
Core Challenges
High cost of high-purity raw materials and unstable quality of mid-to-low-end products: High-purity materials squeeze profit margins; mid-to-low-end materials suffer batch-to-batch quality fluctuations and impurity instability, posing filing risks.
Weak supply chain resilience: Reliance on single or a small number of suppliers leads to peak-season stockouts, delayed deliveries and quality fluctuations affecting new product launches.
High international certification costs: High expenses for COSMOS, ECOCERT and other certifications are unaffordable for mid-sized brands, hindering overseas expansion.
Core Opportunities
Precise positioning in "plant-derived whitening + skin repair": Glabridin’s mild and high-efficiency properties suit sensitive skin perfectly, aligning with the clean beauty trend to build differentiation and high user stickiness.
Regional supply chain advantages: Proximity to major producing countries (China, Turkey, Iran) shortens procurement cycles, reduces logistics costs and improves communication efficiency.
Synthetic biology dividend: Early deployment of pilot-scale biosynthesis raw materials to seize market share amid future cost reduction and capacity expansion.
Characteristics: Small batch procurement, frequent trial orders, tight budgets, high flexibility, cost sensitivity and weak compliance capabilities.
Core Challenges
Low bargaining power for small-batch orders with high minimum order quantities: High unit prices and inventory pressure for small-batch high-purity procurement.
Unstable product quality and high filing risks: Low-priced materials often feature falsely labeled purity, excessive impurities and batch discrepancies, hindering whitening special certificate applications and posing product removal risks.
Decentralized supply chain and high management costs: Diverse suppliers with uneven qualifications increase screening, audit and testing costs, alongside risks of supply disruption and adulteration.
Core Opportunities
Flexible supply chain dividend: Choose suppliers supporting small-batch and multi-specification orders with quick sample production (1kg/5kg minimum order) to reduce trial costs and accelerate product iteration.
Differentiated niche market positioning: Avoid head-on competition in the high-end market; focus on niche segments including sensitive skin repair, post-procedure soothing, sunscreen repair and affordable whitening by adopting medium-to-high purity (40%–90%) materials to launch cost-effective blockbuster products.
Cost reduction through collaborative procurement: Unite multiple small and medium brands for centralized purchasing to enhance bargaining power and share testing & certification costs.
Characteristics: New market entrants with limited raw material expertise, divergent industry standards, rapid demand growth and special compliance requirements.
Core Challenges
Standard misalignment and detection difficulties: Cosmetic-grade purity, impurity, microorganism and solvent residue standards cannot directly adapt to food-grade and pharmaceutical-grade requirements.
Supplier matching barriers: Traditional cosmetic raw material suppliers lack food/pharmaceutical compliance experience, while food/pharmaceutical raw material manufacturers do not produce glabridin, creating a supply-demand mismatch.
High operational risks from insufficient industry knowledge: Lack of understanding of purity-efficacy correlation, raw material stability, formulation compatibility and regulatory restrictions leads to high risks of formula failure and regulatory penalties.
Core Opportunities
Blue ocean incremental market: Explosive growth in oral whitening, anti-allergy and medical aesthetics repair markets with low competition and high premium space; early layout secures first-mover advantages.
Standard co-creation opportunities: Collaborate with raw material suppliers to formulate food/pharmaceutical-grade glabridin standards, building technical barriers and locking exclusive supply chains.
Broad compound innovation space: Develop multi-effect products and enhance competitiveness by compounding glabridin with vitamins, collagen, probiotics and plant polysaccharides.
Practical actionable strategies for each buyer category are listed below for direct implementation.
Supply Chain Strategy
Adopt dual/multi-source high-purity capacity locking: Sign 3–5 year long-term agreements with 2–3 suppliers featuring stable high-purity production capacity, global certifications and traceability systems, specifying annual supply volume, price range, quality standards, delivery guarantees and compensation clauses for breach of contract.
Upstream industrial layout: Hold equity stakes or establish joint ventures in Glycyrrhiza glabra GAP planting bases to ensure raw material stability, control pesticide residues and reduce costs.
Deploy biosynthesis layout: Jointly develop exclusive strains and processes with synthetic biology enterprises to partially replace natural high-purity materials after 2028 for cost reduction and capacity expansion.
Quality & Compliance
Establish unified global internal standards: Set internal control standards higher than industry averages for purity (≥98.5%), heavy metals (≤10ppm), pesticide residues, solvent residues and microorganisms; require full-batch COA reports from suppliers.
Full-chain ESG traceability: Mandate suppliers to provide blockchain traceability, carbon footprint reports and sustainable procurement certificates covering the entire chain from planting and extraction to packaging and transportation.
Product & Market Layout
High-end product lines adopt ≥98% high-purity glabridin: Highlight its positioning as the "Whitening Gold" with advantages of melanin inhibition, anti-inflammatory repair and sensitive skin compatibility, supporting high-end pricing and strong brand image.
Mid-to-high-end lines adopt compound formulations with 40%–90% medium-to-high purity glabridin: Compound with niacinamide, tranexamic acid, vitamin C and centella asiatica to build a multi-path whitening and repair matrix with higher cost performance.
Supply Chain Strategy
Adopt one primary + one alternative supplier model: Select a primary supplier with stable high-purity output, reasonable pricing, international certifications and efficient communication; reserve a regional alternative supplier with sufficient production capacity, controllable quality and rapid response to avoid supply disruption.
Tiered procurement and flexible bargaining: Place quarterly/semi-annual orders with volume-linked tiered discounts and peak-season price locking to balance costs and inventory pressure.
Track synthetic biology progress: Maintain technical exchanges with pilot-stage biosynthesis enterprises and conduct small-batch trials after 2027 to lay the foundation for future cost reduction.
Quality & Compliance
Adopt ≥98% high-purity glabridin exclusively for whitening special-certified product lines: Complete strict regulatory filing and full-item testing with complete documentation to avoid product removal risks.
Adopt 40%–90% medium-to-high purity materials for general repair/sunscreen products: Prioritize control of key impurities, batch stability and microbial indicators with cost performance as the core consideration.
Gradually upgrade international certifications: Prioritize COSMOS/ECOCERT certification to meet basic overseas expansion requirements and enhance brand image.
Product & Market Layout
Focus on "plant-derived whitening + sensitive skin repair": Highlight mild efficacy, anti-inflammatory redness reduction, skin barrier repair and non-irritation to build differentiated advantages and high user stickiness.
Regional market adaptation: Optimize formula concentration and compound systems targeting Asian yellow skin and high sensitive skin prevalence to enhance efficacy and skin feel experience.
Supply Chain Strategy
Select flexible suppliers: Prioritize suppliers supporting small-batch (1kg/5kg minimum order), multi-specification customization, rapid sample production, short delivery cycles and transparent pricing to reduce inventory and trial costs.
Centralized procurement and joint bargaining: Unite 3–5 peer brands/foundries for bulk ordering to enhance bargaining power and share testing & certification costs.
Avoid high-purity red ocean competition: Prioritize 40%–90% medium-to-high purity materials with sufficient supply, cost performance and low filing difficulty.
Quality & Compliance
Strictly control key indicators: Focus on verifying purity, heavy metals, solvent residues and microorganisms; reject raw materials with false labeling and severe batch discrepancies.
Compliance risk avoidance: Adopt ≥98.5% high-purity materials with complete filing for whitening special-certified lines; use 40%–90% materials for general repair lines without false whitening efficacy claims to reduce regulatory risks.
Simplify certification layout and focus on rigid demands: Prioritize domestic filing, ISO and GMP certification; postpone high-cost international certifications to control operating costs.
Product & Market Layout
Focus on niche segmented scenarios: Avoid head-on competition with high-end brands; target sensitive skin repair, post-procedure soothing, sunscreen repair and affordable whitening to accurately reach target consumers.
Iterate products rapidly with small-batch trials: Conduct small-batch trial production, collect market feedback, optimize formulas and launch new products quickly to reduce operational risks and seize niche market share.
Supply Chain Strategy
Select suppliers with cross-industry service capabilities: Prioritize suppliers with dual production qualifications for cosmetic and food/pharmaceutical grades, independent testing capabilities and rich compliance experience to avoid standard misalignment.
Small-batch trial orders with gradual volume expansion: Conduct initial 10–50kg small-batch trials to verify raw material quality, stability and formulation compatibility before mass production to mitigate risks.
Quality & Compliance
Formulate customized industry standards: Collaborate with suppliers to formulate dedicated food/pharmaceutical-grade glabridin standards, clarifying strict indicators for purity, heavy metals, pesticide residues, solvent residues, microorganisms and pathogenic bacteria above cosmetic-grade requirements.
Prioritize compliance with complete documentation: Comply with local food additive standards for food-grade applications and pharmacopoeia standards for pharmaceutical-grade products; complete advance filing and full-item testing with complete documentation to avoid regulatory penalties.
Product & Market Layout
Focus on mild and safe efficacy positioning: Launch products focusing on oral whitening, anti-allergy soothing, anti-inflammatory repair and post-procedure recovery, highlighting natural ingredients, mild efficacy, safety and no side effects.
Enhance product value through compound innovation: Compound glabridin with vitamin C, collagen, probiotics and hyaluronic acid/plant polysaccharides to develop multi-effect products and boost competitiveness and premium capacity.
As a new foreign trade service provider driven by technological transformation and foreign trade services, HiSiaddi has deep expertise in the glabridin industry for many years and integrates high-quality global resources. We provide genuine raw material supplies from well-known Chinese glabridin manufacturers for different customer groups, alongside one-stop services including customized formula development, technical support, compliance consulting and global logistics solutions.
+86-13120989737 
info@hisiaddi.com 
English
